Abstract
The aim of this study was to evaluate the efficacy of ozone therapy in the treatment of 50 patients with peripheral vestibulocochlear syndrome. Ozone was injected in the cervical region C2-C3, for 20 sessions. Evaluation criteria was based in the evolution of nystagmus, tinnitus, hearing loss and vertigo. Also, oxidative stress parameters were measured. Results demonstrated that patient improvements, according to vertigo, hearing loss, tinnitus and nystagmus, were of 90, 80, 65 and 100 %, respectively. These patients were initially under condition of systemic oxidative stress, however, at the end of the study a redox balance was achieved. No side effects were observed.
Keywords: Ozone therapy, peripheral vestibulocochlear syndrome, vertigo, nystagmus, hearing loss, tinnitus, oxidative stress
Related Journals
Applied Drug Research, Clinical Trials and Regulatory Affairs
9